Latest Health News
Anavar For Women And Men: CrazyBulk Launch Anavar Legal Steroid Alternative For Female Read Dosage, Side Effects, (Before and After Cycle results)
New York, Aug. 31, 2025 (GLOBE NEWSWIRE) -- August 31, 2025 |…
Amarin Highlights Key Data Providing Mechanistic Insights into Eicosapentaenoic Acid (EPA) at ESC 2025
-- Data Further Advance Understanding of VASCEPA®/VAZKEPA® Potential Mechanisms of Action --…
Novo Nordisks Wegovy cuts risk of heart attack, stroke or death by 57% compared to tirzepatide in real-world study of people with obesity and cardiovascular disease
Compared with tirzepatide, Wegovy® (semaglutide 2.4 mg) showed a significant 57% greater…
KFSHRC Strengthens Its Position as a Fast-Growing Destination for International Patients
RIYADH, Saudi Arabia, Aug. 30, 2025 (GLOBE NEWSWIRE) -- King Faisal Specialist…
Novartis Leqvio shows statistically significant and clinically meaningful early LDL-C goal achievement with less muscle pain
V-DIFFERENCE is first study to show that Leqvio prioritized after statins helps…
Roche and Alnylam advance zilebesiran into global phase III cardiovascular outcomes trial for people with uncontrolled hypertension
Phase III trial informed by comprehensive KARDIA data set generated through three…
New REDUCE-IT Analyses Presented at ESC 2025 Include Data Showing VASCEPA/VAZKEPA (Icosapent Ethyl) Therapy Resulted in 9% Fewer Total Hospitalizations & Reduces Cardiovascular Disease Risk in Certain High-Risk Patient Subgroups
-- 2025 ESC/EAS Dyslipidemia Guideline Focused Update Reaffirms High Dose Icosapent Ethyl…
KFSHRC Sets Global Benchmark in Robotic Surgery, Expanding World-First Innovations
RIYADH, Saudi Arabia, Aug. 29, 2025 (GLOBE NEWSWIRE) -- King Faisal Specialist…
Outliyr Releases Biological Age Testing Case Study Revealing 13.1-Year Variation Across Seven Products
Austin, TX, Aug. 29, 2025 (GLOBE NEWSWIRE) -- Outliyr, a platform for…
